MDT

97.56

-1.22%↓

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

MDT

97.56

-1.22%↓

148.57

+2%↑

VEEV

239.64

-0.58%↓

HQY

94.29

-4.24%↓

PHR.US

17.17

+1.72%↑

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

38.61 2.03

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

36.79

Max

38.67

Põhinäitajad
By Trading Economics
Sissetulek	11M 51M
Müük	39M 239M
P/E Sektori keskmine	11.593 87.826
Aktsiakasum	1.08
Kasumimarginaal	21.242
Töötajad	268
EBITDA	14M 73M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+16.72% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	24. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	429M 2.1B
Eelmine avamishind	36.58
Eelmine sulgemishind	38.61

Uudiste sentiment

By Acuity

34%

66%

111 / 372 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. jaan 2026, 23:08 UTC

Omandamised, ülevõtmised, äriostud

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8. jaan 2026, 21:39 UTC

Omandamised, ülevõtmised, äriostud

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8. jaan 2026, 20:54 UTC

Omandamised, ülevõtmised, äriostud

Glencore, Rio Tinto Restart Merger Talks -- Update

8. jaan 2026, 20:44 UTC

Omandamised, ülevõtmised, äriostud

Glencore, Rio Tinto Restart Merger Talks

8. jaan 2026, 17:05 UTC

Omandamised, ülevõtmised, äriostud

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8. jaan 2026, 16:43 UTC

Suurimad hinnamuutused turgudel

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8. jaan 2026, 23:44 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

8. jaan 2026, 23:37 UTC

Market Talk

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8. jaan 2026, 22:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. jaan 2026, 22:42 UTC

Market Talk

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8. jaan 2026, 22:30 UTC

Omandamised, ülevõtmised, äriostud

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8. jaan 2026, 21:53 UTC

Tulu

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. jaan 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8. jaan 2026, 21:10 UTC

Omandamised, ülevõtmised, äriostud

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8. jaan 2026, 21:09 UTC

Market Talk

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8. jaan 2026, 21:09 UTC

Omandamised, ülevõtmised, äriostud

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8. jaan 2026, 20:21 UTC

Market Talk

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8. jaan 2026, 19:44 UTC

Market Talk

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8. jaan 2026, 18:50 UTC

Market Talk

Mexico's Industrial Production Seen Lower in November -- Market Talk

8. jaan 2026, 17:48 UTC

Tulu

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8. jaan 2026, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. jaan 2026, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8. jaan 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

8. jaan 2026, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. jaan 2026, 16:45 UTC

Market Talk

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8. jaan 2026, 16:03 UTC

Market Talk

Global Equities Roundup: Market Talk

8. jaan 2026, 16:03 UTC

Market Talk

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8. jaan 2026, 16:02 UTC

Market Talk

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8. jaan 2026, 15:23 UTC

Omandamised, ülevõtmised, äriostud

Paramount Defends Its Hostile Bid for Warner -- Update

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

16.72% tõus

12 kuu keskmine prognoos

Keskmine 43.83 USD 16.72%

Kõrge 55 USD

Madal 32 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

111 / 372 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.